MD3803G2 - Method of treating hyperkinesia of children - Google Patents

Method of treating hyperkinesia of children

Info

Publication number
MD3803G2
MD3803G2 MDA20080096A MD20080096A MD3803G2 MD 3803 G2 MD3803 G2 MD 3803G2 MD A20080096 A MDA20080096 A MD A20080096A MD 20080096 A MD20080096 A MD 20080096A MD 3803 G2 MD3803 G2 MD 3803G2
Authority
MD
Moldova
Prior art keywords
compositum
months
day during
homaccord
pill
Prior art date
Application number
MDA20080096A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3803F1 (en
Inventor
Светлана ХАДЖИУ
Original Assignee
Светлана ХАДЖИУ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Светлана ХАДЖИУ filed Critical Светлана ХАДЖИУ
Priority to MDA20080096A priority Critical patent/MD3803G2/en
Publication of MD3803F1 publication Critical patent/MD3803F1/en
Publication of MD3803G2 publication Critical patent/MD3803G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention refers to medicine, namely neurology, pediatry, reflexotherapy and can be used for treating children with hyperkinesiae.The method, according to the invention, consists in that the patient is administered per os the preparations Lymphomyosot, Berberis-Homaccord, Gelsemium-Homaccord 5-10 drops 3 times a day during 1...2 months and sublingually Nervoheel 1 pill 3 times a day during 1...3 months, Spascupreel and Spigelon 1 pill 3 times a day during 1...2 months. Beginning with the second week of treatment there are subcutaneously introduced the preparations Cerebrum compositum N 2,2 ml, TraumeelS 2,2 ml, Placenta compositum 2,2 ml, Coenzyme compositum 2,2 ml, Ubichinon compositum 2,2 ml, 1...2 times a week in the region of biologically active points E 36, 40, 44; G 11, 14, 18; MC 6; RP 6, 9; C 5, 7; V 1, 6, 10, 11, 15, 60, 62, 63, 64; VB 1, 16, 20, 41; T 2, 3, 16, 17, 21, 22; IG 3; TR 23; P 3, 7 during 5 weeks, at the same time in each biologically active point is introduced a single indicated medicinal preparation and each preparation is introduced in 3...5 points.
MDA20080096A 2008-03-31 2008-03-31 Method of treating hyperkinesia of children MD3803G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080096A MD3803G2 (en) 2008-03-31 2008-03-31 Method of treating hyperkinesia of children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080096A MD3803G2 (en) 2008-03-31 2008-03-31 Method of treating hyperkinesia of children

Publications (2)

Publication Number Publication Date
MD3803F1 MD3803F1 (en) 2009-01-31
MD3803G2 true MD3803G2 (en) 2009-08-31

Family

ID=40347766

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080096A MD3803G2 (en) 2008-03-31 2008-03-31 Method of treating hyperkinesia of children

Country Status (1)

Country Link
MD (1) MD3803G2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD38Z5 (en) * 2009-02-20 2010-02-28 Татьяна ГИДИРИМСКИЙ Method for vision correction to weak-eyed patients
MD25Z (en) * 2009-02-25 2010-02-28 Родика БЫЛБА Method for treating disorders of accommodation apparatus
MD39Z5 (en) * 2009-03-03 2010-02-28 Родика БЫЛБА Method for treating the acquired noncomplicated progressive myopia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019174C1 (en) * 1991-07-15 1994-09-15 Лобзин Владир Семенович Method for curing hyperkinesia of infants
RU2092201C1 (en) * 1994-04-06 1997-10-10 Российская медицинская академия последипломного образования Method for treating tic hyperkinesiae
RU2099079C1 (en) * 1995-12-29 1997-12-20 Санкт-Петербургская государственная педиатрическая медицинская академия Agent for ticosis hyperkinesis treatment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2019174C1 (en) * 1991-07-15 1994-09-15 Лобзин Владир Семенович Method for curing hyperkinesia of infants
RU2092201C1 (en) * 1994-04-06 1997-10-10 Российская медицинская академия последипломного образования Method for treating tic hyperkinesiae
RU2099079C1 (en) * 1995-12-29 1997-12-20 Санкт-Петербургская государственная педиатрическая медицинская академия Agent for ticosis hyperkinesis treatment

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Острейко Т.Я. Клинические проявления и показатели нейромедиаторного обмена синдрома Туретта у детей. Автореферат *
Острейко Т.Я. Клинические проявления и показатели нейромедиаторного обмена синдрома Туретта у детей. Автореферат диссертации канд. мед. наук. Москва, 1992, с.16 *
Смирнов А.Ю. О применении метоклопрамида (церукала) при синдроме Туретта. Невропатология и психиатрия, N 8, 1989, с. 105- *
Смирнов А.Ю. О применении метоклопрамида (церукала) при синдроме Туретта. Невропатология и психиатрия, N 8, 1989, с. 105-108 *

Also Published As

Publication number Publication date
MD3803F1 (en) 2009-01-31

Similar Documents

Publication Publication Date Title
ES2653615T3 (en) Plurality of recombinant LAG-3 dose for use in eliciting an immune response from monocytes
JP2016514132A5 (en)
NZ630790A (en) Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
AR099078A2 (en) A MEDICINAL PRODUCT THAT INCLUDES ACETATO DE GLATIRAMER
NZ608502A (en) Polypeptides that bind to human complement component c5
HUP0102489A2 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
EA201591529A1 (en) TREATMENT OF CHILDREN'S DEFICIENCY OF GROWTH HORMONE BY HUMAN ANALOGUES OF HORMONE GROWTH
RU2015116264A (en) COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN PATIENTS WITH DIABETES
RU2016149316A (en) TREATMENT OF RHEUMATOID ARTHRITIS
JP2019517549A5 (en)
Librodo et al. Chronotherapeutic drug delivery
MD3803G2 (en) Method of treating hyperkinesia of children
JP2016505050A5 (en)
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
UA93365C2 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof
JOP20190019A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN
RU2015115398A (en) N-acetyl-L-cysteine for use in in vitro fertilization
JP2013540734A5 (en)
IL310909A (en) Dosing regimens associated with extended release paliperidone injectable formulations
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
Ananth et al. Benztropine psychosis
JP2019535830A5 (en)
JP2018522881A5 (en)
MX2012005497A (en) Tivozanib and temsirolimus in combination.
MD3906G2 (en) Method for treating the neurotic enuresis to children

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees